GleamWall
中文EN

CAMT CAMTEK LTD

Optical Instruments & Lenses · Nasdaq · SEC CIK 1109138 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY15.6%
TTM net income YoY-57.2%
TTM EPS YoY-57.0%
Revenue 3-yr CAGR15.6%
Net income 3-yr CAGR-14.1%

Margins

Gross margin50.5%
Operating margin25.8%
Net margin10.2%
FCF margin25.7%
EBITDA margin28.2%

Returns

ROE8.7%
ROA4.7%
ROIC (approx.)28.8%
Asset turnover0.46x

Leverage & solvency

Liabilities / assets51.0%
Debt / equity0.00x
Current ratio8.35x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.80x
Accruals ratio-8.5%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2021Q22021-06-302021Q12021-03-312020Q22020-06-302020Q12020-03-312019Q22019-06-302019Q12019-03-312018Q22018-06-302017Q22017-06-30
Income statement
Revenue$67.45M—$37.00M—$34.35M—$30.46M$22.68M
Cost of revenue$32.46M—$20.06M—$17.78M—$15.56M$11.53M
Gross profit$34.99M—$16.94M—$16.57M—$14.90M$11.15M
R&D expense$5.77M—$4.75M—$3.80M—$3.41M$3.41M
SG&A expense$12.19M—$6.78M—$6.41M—$6.78M$5.75M
Operating income$17.04M—$5.41M—$6.35M—$4.72M-$11.01M
Pretax income$17.22M—$5.69M—$6.49M—$4.86M-$11.07M
Income tax$1.56M—$378,000—$463,000—$533,000-$5.40M
Net income$15.65M$13.36M$5.31M$2.78M$7.19M$6.03M$4.33M-$3.88M
EBITDA$17.69M—$5.94M—$6.85M—$5.19M-$10.49M
EPS (basic)0.36—0.14—0.19—0.12-0.11
EPS (diluted)0.35—0.13—0.19—0.12-0.11
Weighted avg. shares (diluted)44.75M—39.95M—37.73M—36.63M35.37M
Balance sheet
Cash & equivalents$80.34M$54.95M$32.47M$49.09M$85.27M$61.02M$41.20M$27.12M
Receivables$60.26M—$39.53M———$32.28M$21.37M
Inventory$54.35M—$29.54M———$23.69M$20.68M
Current assets$308.36M—$174.06M———$99.94M$98.08M
PP&E, net$20.38M—$18.80M———$15.73M$15.62M
Intangibles$602,000—$574,000———$480,000$474,000
Total assets$344.15M—$197.32M———$121.08M$125.37M
Current liabilities$81.33M—$48.73M———$31.73M$51.25M
Total liabilities$84.98M—$50.83M———$32.60M$52.17M
Shareholders' equity$259.16M$242.00M$146.49M$139.96M$132.22M$108.27M$88.49M$73.20M
Shares outstanding43.71M—39.03M———36.18M35.40M
Cash flow statement
Operating cash flow$19.89M—$11.13M—$7.02M—-$985,000$3.80M
Capital expenditure$802,000—$365,000—$196,000—$836,000$974,000
Free cash flow$19.09M—$10.76M—$6.82M—-$1.82M$2.83M
Investing cash flow$5.18M—-$27.99M—$1.03M—-$770,000-$1.00M
Financing cash flow$45,000—$276,000—$16.16M—-$4.45M$182,000
Depreciation & amortization$648,000—$531,000—$498,000—$471,000$520,000
Stock-based compensation$1.47M—$951,000—$605,000—$249,000$114,000

Free plan shows the latest 8 periods; Pro shows all 10 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.